0

Ylber Jani

Republic of Albania , Republic of Albania

Title: Use of C-reactive protein for prediction of sinus rhythm maintenance after pharmacologic cardioversion in patients with Metabolic Syndrome.

Abstract

BACKGROUND: Approximately 50% of patients undergoing cardioversion usually present with recurrence of Atrial Fibrillation(AF) within 3–6 months of cardioversion despite ongoing antiarrhythmic treatment(AAD). Inflammation have been involved in the pathogenesis of both metabolic syndrome(MS) and AF. Evidence has indicated that inflammatory changes is essential for recurrence of AF. Therefore, identifying patients at high risk of AF recurrence remains challenging. 

OBJECTIVE: We tested hypothesis: increased C-reactive protein (CRP) levels are associated with greater risk of AF recurrence after pharmacologic cardioversion (PCV).

METHODS: We conducted a multicenter observational cross-sectional study.215 consecutive adult  participants(≥18 and <65years of age) were recruited with  MS  and symptomatic AF(paroxysmal and persistent),admitted  at 6 general cardiology  Health Care Clinics ,who underwent PCV, during 1 calendar  year  follow-up period,stratified in two group according to CRP levels,(105 participants(50 females and 55 males) with level of CRP ≥3mg/l, and 110(58 females and 52 males) with level of CRP <3mg/l). Recurrence of AF,during  follow-up period was defined as the study end-point.
RESULTS: After the  follow-up of 1.0 years,only(31.8%) of patients with MS and CRP  levels above the cut-off of 3 mg/l, remain in sinus rhythm,compared to (64.7%) of  patients with MS and  CRP levels below the cut-off of 3 mg/l.(p=0.002). 

CONCLUSIONS: CRP an easily determined marker in everyday clinical practice may provide significant prognostic information regarding sinus rhythm maintenance  and  could be useful for predicting  recurrence of AF after successful pharmacologic cardioversion in clinical practice.

Biography

To be updated soon...